Patents by Inventor Ching-Peng Wei

Ching-Peng Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11148993
    Abstract: The present invention relates to a method for purifying polyunsaturated fatty acid using a continuous reactor, and the method comprises: (a) complexing step, (b) cleaning step, (c) extracting step, and (d) concentrating and drying step. The method of the present invention reacts a polyunsaturated fatty acid and a silver salt aqueous solution in a continuous reactor to form a complex of the polyunsaturated fatty acid and silver, and then cleans the complex with a first organic solvent to improve the purity of the complex; afterwards, a second organic solvent is used to extract the purified polyunsaturated fatty acid. The method of the present invention can continuously produce polyunsaturated fatty acids with high yield and high purity.
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: October 19, 2021
    Assignee: CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO. LTD.
    Inventors: Ching-Peng Wei, Yen-Shih Tung, Tzu-Ai Lee, Jenn-Line Sheu
  • Patent number: 10336835
    Abstract: The present invention provides a crystalline form of Suagmmadex sodium, characterized by an X-ray powder diffraction pattern. The present invention further provides crystalline forms of Suagmmadex sodium for use in the manufacture of a pharmaceutical composition or a medicament. The present invention further provides a pharmaceutical composition comprising the crystalline form of Sugammadex sodium of the present invention and at least one pharmaceutical acceptable excipient.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: July 2, 2019
    Assignee: FORMOSA LABORATORIES, INC.
    Inventors: Yu-Liang Liu, Ching-Peng Wei
  • Patent number: 10233263
    Abstract: The present invention provides a method for improved preparation of Sugammadex sodium.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: March 19, 2019
    Assignee: FORMOSA LABORATORIES, INC.
    Inventors: Yu-Liang Liu, Ching-Peng Wei
  • Publication number: 20190062459
    Abstract: The present invention provides a method for improved preparation of Sugammadex sodium.
    Type: Application
    Filed: August 23, 2017
    Publication date: February 28, 2019
    Applicant: FORMOSA LABORATORIES, INC.
    Inventors: Yu-Liang Liu, Ching-Peng Wei
  • Publication number: 20190062460
    Abstract: The present invention provides a crystalline form of Suagmmadex sodium, characterized by an X-ray powder diffraction pattern. The present invention further provides crystalline forms of Suagmmadex sodium for use in the manufacture of a pharmaceutical composition or a medicament. The present invention further provides a pharmaceutical composition comprising the crystalline form of Sugammadex sodium of the present invention and at least one pharmaceutical acceptable excipient.
    Type: Application
    Filed: August 23, 2017
    Publication date: February 28, 2019
    Applicant: FORMOSA LABORATORIES, INC.
    Inventors: Yu-Liang Liu, Ching-Peng Wei
  • Patent number: 10023603
    Abstract: The present invention provides preparations of monosaccharides, disaccharides, trisaccharides, and pentasaccharides of heparinoids. The present invention also provides novel monosaccharides, disaccharides, trisaccharides and pentasaccharides for use in the preparation of heparinoids.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: July 17, 2018
    Assignee: Formosa Laboratories, Inc.
    Inventors: Yu-Liang Liu, Ching-Peng Wei
  • Publication number: 20170073304
    Abstract: The present invention relates to a method for preparation of Teriflunomide, comprising steps of: (a) adding Leflunomide to an alcoholic solvent to give solution (I); (b) adding an aqueous sodium hydroxide solution slowly into the solution (I) to give solution (II); (c) acidifying the solution (II) with inorganic acid for precipitation to give solution (III); and (d) filtering the solution (III) to give Teriflunomide.
    Type: Application
    Filed: September 10, 2015
    Publication date: March 16, 2017
    Applicant: FORMOSA LABORATORIES INC.
    Inventors: CHING-PENG WEI, PEI-CHEN HUANG
  • Publication number: 20170015695
    Abstract: The present invention provides preparations of monosaccharides, disaccharides, trisaccharides, and pentasaccharides of heparinoids. The present invention also provides novel monosaccharides, disaccharides, trisaccharides and pentasaccharides for use in the preparation of heparinoids.
    Type: Application
    Filed: March 30, 2016
    Publication date: January 19, 2017
    Applicant: FORMOSA LABORATORIES, INC.
    Inventors: Yu-Liang Liu, Ching-Peng Wei
  • Publication number: 20140051875
    Abstract: The present invention relates to maxacalcitol hydrate, a new crystalline form of maxacalcitol, with superior technical properties e.g. in the manufacture of crystal suspension formulations, and with superior stability properties.
    Type: Application
    Filed: August 16, 2013
    Publication date: February 20, 2014
    Applicant: FORMOSA LABORATORIES INC.
    Inventors: CHING-PENG WEI, PEI-CHEN HUANG
  • Publication number: 20130123433
    Abstract: The present invention provides a method for preparing poly(allylamine) hydrochloride, sevelamer hydrochloride, sevelamer carbonate and colesevelam hydrochloride. The present invention also relates to a process for preparing oly(allylamine) hydrochloride, sevelamer hydrochloride, sevelamer carbonate and colesevelam hydrochloride with low allylamine content and high specific gravity.
    Type: Application
    Filed: November 14, 2011
    Publication date: May 16, 2013
    Applicant: FORMOSA LABORATORIES, INC.
    Inventors: YU-LIANG LIU, CHING-PENG WEI
  • Patent number: 8399675
    Abstract: This invention relates to novel compounds and a process for preparation of montelukast sodium.
    Type: Grant
    Filed: February 22, 2010
    Date of Patent: March 19, 2013
    Assignee: Formosa Laboratories, Inc.
    Inventors: Jui-Te Hung, Ching-Peng Wei
  • Publication number: 20120108811
    Abstract: This present invention provides an improved process for preparing Temozolomide (TMZ) stable at room temperature for at least 18 months. This present invention also relates to Temozolomide stable at room temperature for at least 18 months.
    Type: Application
    Filed: October 28, 2010
    Publication date: May 3, 2012
    Applicant: FORMOSA LABORATORIES INC.
    Inventors: Mei-Jing Lee, Ching-Peng Wei
  • Publication number: 20120108554
    Abstract: The present invention relates to a process for purifying Doxercalciferol, a synthetic vitamin D analog, also known as 1?-hydroxy vitamin D2, to the purity greater than 99.5% by crystallization from a mixed solvent of methanol and acetonitrile. Each of the individual impurities can be controlled no more than 0.1% which meets the individual unknown impurities specification requirement of International Conference on Harmonisation (ICH) guideline. The crystallization yield is more than 75% which is suitable for employed as a commercial process.
    Type: Application
    Filed: October 28, 2010
    Publication date: May 3, 2012
    Applicant: FORMOSA LABORATORIES, INC.
    Inventors: Bang-I Liou, Ching-Peng Wei
  • Patent number: 8026379
    Abstract: The present invention relates to a compound and a novel process for the preparation of Paricalcitol intermediates.
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: September 27, 2011
    Assignee: Formosa Laboratories, Inc.
    Inventors: Chze-Siong Ng, Ching-Peng Wei
  • Publication number: 20110137058
    Abstract: This invention relates to a method for purifying Paricalcitol by reverse phase chromatography. This invention also relates to a purified Paricalcitol prepared by said method. This invention further relates to a method for purifying Paricalcitol by crystallization.
    Type: Application
    Filed: February 15, 2011
    Publication date: June 9, 2011
    Applicant: FORMOSA LABORATORIES, INC.
    Inventors: CHZE-SIONG NG, CHING-PENG WEI
  • Publication number: 20100152453
    Abstract: This invention relates to novel compounds and a process for preparation of montelukast sodium.
    Type: Application
    Filed: February 22, 2010
    Publication date: June 17, 2010
    Applicant: FORMOSA LABORATORIES, INC.
    Inventors: Jui-Te Hung, Ching-Peng Wei
  • Patent number: 7700776
    Abstract: This invention relates to novel compounds and a process for preparation of montelukast sodium.
    Type: Grant
    Filed: October 24, 2006
    Date of Patent: April 20, 2010
    Assignee: Formosa Laboratories, Inc.
    Inventors: Jui-Te Hung, Ching-Peng Wei
  • Patent number: 7645911
    Abstract: The invention relates to a novel process for the preparation of Paricalcitol and intermediates thereof.
    Type: Grant
    Filed: July 25, 2008
    Date of Patent: January 12, 2010
    Assignee: Formosa Laboratories, Inc.
    Inventors: Chze Siong Ng, Ching-Peng Wei
  • Publication number: 20090318722
    Abstract: The present invention relates to a compound and a novel process for the preparation of Paricalcitol intermediates.
    Type: Application
    Filed: June 20, 2008
    Publication date: December 24, 2009
    Applicant: FORMOSA LABORATORIES INC.
    Inventors: Chze-Siong Ng, Ching-Peng Wei
  • Publication number: 20090275768
    Abstract: This invention relates to a method for purifying Paricalcitol by reverse phase chromatography. This invention also relates to a purified Paricalcitol prepared by said method. This invention further relates to a method for purifying Paricalcitol by crystallization.
    Type: Application
    Filed: April 30, 2008
    Publication date: November 5, 2009
    Applicant: FORMOSA LABORATORIES, INC.
    Inventors: Chze-Siong Ng, Ching-Peng Wei